The Case for TAVR in “Low-Risk” Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Jeffrey J. Popma

REGISTER for free or LOG IN to view this content

The Case for TAVR in “Low-Risk” Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

We Recommend